CannaPharmaRX, Inc. (CPMD)
OTCMKTS · Delayed Price · Currency is USD
0.0034
-0.0014 (-29.17%)
Oct 27, 2025, 2:48 PM EDT
CannaPharmaRX Market Cap
CannaPharmaRX has a market cap or net worth of $3.15 million as of October 27, 2025. Its market cap has decreased by -52.00% in one year.
Market Cap
3.15M
Enterprise Value
21.58M
Revenue
1.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 29, 1999, CannaPharmaRX's market cap has decreased from 27.64M to 3.15M, a decrease of -88.60%. That is a compound annual growth rate of -8.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 3.15M | -40.74% |
| Dec 31, 2024 | 5.32M | 622.75% |
| Dec 29, 2023 | 735.50K | -71.38% |
| Dec 30, 2022 | 2.57M | 62.24% |
| Dec 31, 2021 | 1.58M | -92.76% |
| Dec 31, 2020 | 21.89M | -52.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 618.32M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| American Oncology Network | 291.52M |